The Vanguard Group 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 1:29 pm Unchanged |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
The Vanguard Group | 2,635,520 4.670% |
0 (Unchanged) |
Filing |
| 2024-11-04 12:37 pm Unchanged |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
The Vanguard Group | 2,635,520 4.670% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:39 am Unchanged |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
The Vanguard Group | 2,635,520 4.670% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:39 am Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
The Vanguard Group | 2,635,520 4.670% |
579,813 (+28.21%) |
Filing |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Astria Therapeutics, Inc. ATXS |
The Vanguard Group | 2,055,707 5.660% |
2,055,707 (New Position) |
Filing |